FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148791851> ?p ?o ?g. }

• W2148791851 endingPage "402" @default.
• W2148791851 startingPage "402" @default.
• W2148791851 abstract "Trigeminal neuralgia (TN) is a rare severe unilateral facial pain condition. Current guidelines in trigeminal neuralgia management recommend sodium channel blockers – carbamazepine or oxcarbazepine – as the first-line treatment. However, the currently available drugs are often associated with poor tolerability resulting in sub-optimal pain control. CNV1014802 is a novel sodium channel blocker that is being assessed in the treatment of trigeminal neuralgia. Due to the severity of the condition, it is not ethical to conduct a traditional placebo-controlled randomized controlled trial. It is also difficult to use an active control such as carbamazepine, the current gold standard, because of its complex pharmacology and potential for drug interactions. The trial uses a randomized withdrawal design to assess efficacy in this rare condition. There is a 21-day open-label phase followed by a randomized 28-day placebo-controlled phase for responders. Thirty patients will be randomized. The primary outcome measure will be pain relief, but secondary measures of quality of life will be of significant importance given the effect of this condition on activities of daily living. Safety and adverse event endpoints are described. There have been very few well-controlled, randomized, placebo-controlled studies in trigeminal neuralgia, and the majority of drugs have had other primary uses. Due to the severity of the pain, minimizing the time a patient is administered placebo was a key factor in designing this study. This study will not only provide data on the efficacy of CNV1014802 in trigeminal neuralgia, but will also provide information on the effectiveness and acceptability of a novel trial design in trigeminal neuralgia. Trial number NCT01540630" @default.
• W2148791851 created "2016-06-24" @default.
• W2148791851 creator A5024339865 @default.
• W2148791851 creator A5029582520 @default.
• W2148791851 creator A5035127271 @default.
• W2148791851 creator A5036095513 @default.
• W2148791851 creator A5038787671 @default.
• W2148791851 creator A5045549095 @default.
• W2148791851 creator A5051621255 @default.
• W2148791851 creator A5084885684 @default.
• W2148791851 date "2013-01-01" @default.
• W2148791851 modified "2023-09-26" @default.
• W2148791851 title "Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia" @default.
• W2148791851 cites W1799229938 @default.
• W2148791851 cites W1971500956 @default.
• W2148791851 cites W1979145649 @default.
• W2148791851 cites W1979511665 @default.
• W2148791851 cites W1979976727 @default.
• W2148791851 cites W1980762531 @default.
• W2148791851 cites W1981706023 @default.
• W2148791851 cites W1981761967 @default.
• W2148791851 cites W1983656228 @default.
• W2148791851 cites W1988889619 @default.
• W2148791851 cites W1995051534 @default.
• W2148791851 cites W2015912022 @default.
• W2148791851 cites W2017924471 @default.
• W2148791851 cites W2022936635 @default.
• W2148791851 cites W2025033730 @default.
• W2148791851 cites W2040304670 @default.
• W2148791851 cites W2040556627 @default.
• W2148791851 cites W2047171567 @default.
• W2148791851 cites W2049221399 @default.
• W2148791851 cites W2049321668 @default.
• W2148791851 cites W2051844633 @default.
• W2148791851 cites W2052963366 @default.
• W2148791851 cites W2053020884 @default.
• W2148791851 cites W2064781491 @default.
• W2148791851 cites W2066791546 @default.
• W2148791851 cites W2087998451 @default.
• W2148791851 cites W2098284778 @default.
• W2148791851 cites W2105525460 @default.
• W2148791851 cites W2112146030 @default.
• W2148791851 cites W2114385085 @default.
• W2148791851 cites W2142323737 @default.
• W2148791851 cites W2147196890 @default.
• W2148791851 cites W2151515134 @default.
• W2148791851 cites W2171811563 @default.
• W2148791851 doi "https://doi.org/10.1186/1745-6215-14-402" @default.
• W2148791851 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4222641" @default.
• W2148791851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24267010" @default.
• W2148791851 hasPublicationYear "2013" @default.
• W2148791851 type Work @default.
• W2148791851 sameAs 2148791851 @default.
• W2148791851 citedByCount "47" @default.
• W2148791851 countsByYear W21487918512014 @default.
• W2148791851 countsByYear W21487918512015 @default.
• W2148791851 countsByYear W21487918512016 @default.
• W2148791851 countsByYear W21487918512017 @default.
• W2148791851 countsByYear W21487918512018 @default.
• W2148791851 countsByYear W21487918512019 @default.
• W2148791851 countsByYear W21487918512020 @default.
• W2148791851 countsByYear W21487918512021 @default.
• W2148791851 countsByYear W21487918512022 @default.
• W2148791851 countsByYear W21487918512023 @default.
• W2148791851 crossrefType "journal-article" @default.
• W2148791851 hasAuthorship W2148791851A5024339865 @default.
• W2148791851 hasAuthorship W2148791851A5029582520 @default.
• W2148791851 hasAuthorship W2148791851A5035127271 @default.
• W2148791851 hasAuthorship W2148791851A5036095513 @default.
• W2148791851 hasAuthorship W2148791851A5038787671 @default.
• W2148791851 hasAuthorship W2148791851A5045549095 @default.
• W2148791851 hasAuthorship W2148791851A5051621255 @default.
• W2148791851 hasAuthorship W2148791851A5084885684 @default.
• W2148791851 hasBestOaLocation W21487918511 @default.
• W2148791851 hasConcept C118552586 @default.
• W2148791851 hasConcept C141071460 @default.
• W2148791851 hasConcept C142724271 @default.
• W2148791851 hasConcept C168563851 @default.
• W2148791851 hasConcept C197934379 @default.
• W2148791851 hasConcept C203092338 @default.
• W2148791851 hasConcept C204787440 @default.
• W2148791851 hasConcept C27081682 @default.
• W2148791851 hasConcept C2778186239 @default.
• W2148791851 hasConcept C2778375690 @default.
• W2148791851 hasConcept C2779253243 @default.
• W2148791851 hasConcept C2780355897 @default.
• W2148791851 hasConcept C2781176495 @default.
• W2148791851 hasConcept C42219234 @default.
• W2148791851 hasConcept C71924100 @default.
• W2148791851 hasConcept C98274493 @default.
• W2148791851 hasConceptScore W2148791851C118552586 @default.
• W2148791851 hasConceptScore W2148791851C141071460 @default.
• W2148791851 hasConceptScore W2148791851C142724271 @default.
• W2148791851 hasConceptScore W2148791851C168563851 @default.
• W2148791851 hasConceptScore W2148791851C197934379 @default.
• W2148791851 hasConceptScore W2148791851C203092338 @default.
• W2148791851 hasConceptScore W2148791851C204787440 @default.
• W2148791851 hasConceptScore W2148791851C27081682 @default.

• next